Charles Schwab Investment Management Inc Landec Corp \Ca\ Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 10,427 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,427
Previous 10,427
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding LNDC
# of Institutions
80Shares Held
21.6MCall Options Held
114KPut Options Held
82.1K-
Wynnefield Capital Inc New York, NY4.92MShares$00.0% of portfolio
-
Legion Partners Asset Management, LLC Los Angeles, CA2.95MShares$00.0% of portfolio
-
Greenhaven Road Investment Management, L.P. Greenwich, CT2.14MShares$00.0% of portfolio
-
22 Nw, LP Seattle, WA1.76MShares$00.0% of portfolio
-
325 Capital LLC New York, NY1.34MShares$00.0% of portfolio
About LANDEC CORP \CA\
- Ticker LNDC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,595,600
- Description
- Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...